Want to see SG:M15 full AI Analyst Report?
Top Page
Matex International Limited
(SGX:M15)
Select Model
Select Model
Rating:45Neutral
Price Target:
S$0.02
▲(5.00% Upside)
Action:Upgraded
Date:07/01/26
The score is primarily held down by weak financial performance: steep revenue contraction, widening losses, and persistently negative operating/free cash flow. The balance sheet is less risky than the income statement (moderate and improved leverage), but shrinking equity and ongoing losses remain key concerns. Technicals appear neutral with price near long-term averages, while valuation is difficult to support given the negative P/E and no dividend yield data.
Positive Factors
Improved Leverage
Lower and improving leverage materially reduces solvency risk and preserves financial flexibility. With debt-to-equity down sharply versus 2020, the company has more room to navigate operating losses, access financing at lower marginal cost, and prioritize restructuring or growth investments if cash generation stabilizes.
Negative Factors
Steep Revenue Decline
A multi-year, severe revenue contraction erodes scale, reduces pricing leverage, and amplifies fixed-cost absorption problems. This shrinking operating base makes margin recovery harder, limits reinvestment capacity, and heightens execution risk for any turnaround plan over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved Leverage
Lower and improving leverage materially reduces solvency risk and preserves financial flexibility. With debt-to-equity down sharply versus 2020, the company has more room to navigate operating losses, access financing at lower marginal cost, and prioritize restructuring or growth investments if cash generation stabilizes.
Read all positive factors
Matex International Limited (M15) vs. iShares MSCI Singapore ETF (EWS)
Market Cap
S$11.35M
Dividend YieldN/A
Average Volume (3M)0.00
Price to Earnings (P/E)―
Beta (1Y)0.33
Revenue Growth-16.32%
EPS Growth-91.78%
CountrySG
Employees65
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding515,698,200
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)1.83
Price to Sales (P/S)1.89
P/FCF Ratio-2.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Matex International Limited Business Overview & Revenue Model
Company Description
Matex International Limited, headquartered in Singapore since its establishment in 1989, specializes in the development, production, and distribution of a diverse range of specialized chemical compounds. The company's operations extend across Sing...
Matex International Limited Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
56
Neutral
Cash Flow
22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.86M | 7.00M | 7.35M | 14.59M | 20.93M |
| Gross Profit | 865.00K | 1.47M | 1.61M | 2.51M | 2.64M |
| EBITDA | -6.51M | -2.55M | -3.23M | 5.39M | -5.01M |
| Net Income | -6.77M | -2.65M | -3.31M | 7.27M | -4.93M |
Balance Sheet | |||||
| Total Assets | 11.85M | 15.24M | 21.40M | 24.25M | 30.22M |
| Cash, Cash Equivalents and Short-Term Investments | 8.36M | 8.86M | 16.37M | 11.92M | 5.66M |
| Total Debt | 1.87M | 1.49M | 3.20M | 4.40M | 6.12M |
| Total Liabilities | 7.82M | 7.29M | 9.15M | 9.15M | 23.14M |
| Stockholders Equity | 6.05M | 9.05M | 12.70M | 14.88M | 7.80M |
Cash Flow | |||||
| Free Cash Flow | -5.28M | -2.97M | -754.00K | -1.25M | -35.00K |
| Operating Cash Flow | -5.19M | -2.40M | -456.00K | -1.17M | 238.00K |
| Investing Cash Flow | 171.00K | -3.23M | 3.82M | 11.77M | -267.00K |
| Financing Cash Flow | 4.72M | -1.88M | 1.12M | -4.82M | 1.91M |
Matex International Limited Technical Analysis
Negative
0.02
Price Trends
0.02
Negative
0.02
Negative
0.02
Negative
Market Momentum
>-0.01
Neutral
100.00
Negative
0.00
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:M15, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of 0.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:M15.
Matex International Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | S$664.79M | 8.36 | 9.20% | 4.40% | -8.74% | -6.08% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | S$44.05M | -4.06 | -19.55% | 0.92% | -7.25% | 95.72% | |
46 Neutral | S$13.32M | -7.50 | ― | ― | ― | ― | |
45 Neutral | S$11.35M | -1.58 | -31.32% | ― | -16.32% | -91.78% | |
44 Neutral | S$43.75M | -0.96 | -33.12% | ― | -54.41% | -10.14% |
* Basic Materials Sector Average
SG:M15
Matex International Limited
0.02
<0.01
15.79%
SG:QES
China Sunsine Chemical Holdings Ltd.
0.69
0.10
17.70%
SG:C05
Chemical Industries Far East Ltd.
0.58
0.10
20.83%
SG:5DS
MegaChem Ltd.
0.49
0.10
25.32%
SG:5WV
AsiaPhos Limited
0.01
0.00
0.00%
SG:C8R
Jiutian Chemical Group Limited
0.02
>-0.01
-21.43%
Matex International Limited Corporate Events
Nanyang New Development Secures Board Continuity as It Seeks Trading Resumption
May 28, 2026
Nanyang New Development Limited held its annual general meeting in Singapore on 30 April 2026, where shareholders adopted the audited financial statements for the year ended 31 December 2025. Management reported ongoing efforts to boost market sal...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.